Methods We conducted a systematic search of major electronic databases in April 2022.
Studies that included patients with dysplastic and non-dysplastic Barrett's esophagus …

Introduction: Barrett's epithelium (BE) has malignant potential. Neither acid suppression nor
antireflux surgery produce consistent or complete regression of the metaplastic epithelium …

AIM: To report the long-term outcome of patients after complete ablation of non-neoplastic
Barrett's esophagus (BE) with respect to BE relapse and development of intraepithelial …

Background Barrett's esophagus (BE) is a premalignant condition for the development of
esophageal adenocarcinoma. Recently, many endoscopic therapies based on thermal or …

Aim: To determine in a prospective study the efficacy of endoscopic argon plasma
coagulation (APC) in combination with proton pump inhibitors (PPIs) for ablation of Barrett's …

Methods We performed a review of the literature across major databases including
PubMed/MEDLINE, Embase, and Google Scholar. Studies evaluating hybrid-APC alone or …

Argon plasma coagulation (APC) has been used to ablate Barrett's esophagus, however, its
role in the management of non-dysplastic Barrett's esophagus is uncertain. The purpose of …

OBJECTIVE: To investigate the efficacy and safety of the second generation argon plasma
coagulation (VIO APC) in the ablation of Barrett's Esophagus. METHODS: A total of 35 …

Results: The median follow-up period was 36 months (range 12-48). The endoscopic and
histological relapse rates at 1, 12, and 24 months, and end of follow-up were, respectively …

Background: Many modalities have been used to ablate Barrett's oesophagus (BO).
However, long term results and comparative effectiveness are unknown. Aims: Our aim was …